February 24, 2017 / 1:22 PM / 7 months ago

BRIEF-Intellipharmaceutics announces FDA approval for 500 mg and 750 mg generic Glucophage XR

Feb 24 (Reuters) - Intellipharmaceutics International Inc

* Intellipharmaceutics announces FDA approval for 500 mg and 750 mg generic Glucophage® XR

* Intellipharmaceutics International Inc - actively evaluating options to realize commercial returns from new approval Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below